Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase NA 4Phase 4 4Phase 1 4Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 1Phase 1/2 1

Status

Recruiting 4Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

EBV-associated Tumors 1Colorectal Cancer Metastatic 1

Interventions

fludarabine 5Cyclophosphamide 5Surgical Procedures, Operative 2Standard of Care 2Immune Checkpoint Inhibitors 2Bevacizumab 2venetoclax 1tucatinib 1trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1tislelizumab 1tipiracil 1spartalizumab 1sotorasib 1semaglutide 1selpercatinib 1posaconazole 1pembrolizumab 1peginterferon alfa-2b 1osimertinib 1montelukast 1malic acid 1icotinib 1gallium maltolate 1encorafenib 1eliglustat 1durvalumab 1daratumumab 1cannabigerol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Immune Checkpoint Inhibitors × Clear all
NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

The First Affiliated Hospital of Xiamen University

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT07349836 2026-01-20

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Not yet recruiting
40 enrolled

EBV-associated Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡